1. Click here to sign the "Publish the NICE ME/CFS Guideline Now" petition.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 13th September 2021 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

Medscape: More Evidence Anticholinergic Meds Boost Dementia Risk

Discussion in 'Health News and Research unrelated to ME/CFS' started by Andy, May 6, 2018.

  1. Andy

    Andy Committee Member (& Outreach when energy allows)

    Hampshire, UK
    Indigophoton, Trish, Aroa and 9 others like this.
  2. Esther12

    Esther12 Senior Member (Voting Rights)

    I know amitriptyline gets recommended to help with migraines, pain and sleep problems, all things that can be an issue with ME/CFS.
  3. Little Bluestem

    Little Bluestem Senior Member (Voting Rights)

    At one time, depression was the #1 misdiagnosis for ME/CFS. I'll bet a lot of us old-timers have been on anti-depressants. :(
  4. Inara

    Inara Senior Member (Voting Rights)

    There was a previous study about this in 2015: https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2091745?resultClick=3
    This new study works with larger numbers (around 40.000 patients and 280.000 controls).

    Anticholinergic drugs are also "First generation antihistamines like diphenhydramine (Benadryl) and chlorpheniramine (Chlor-Trimeton). Drugs with diphenhydramine are also often taken as a sleep aid." (https://wa-health.kaiserpermanente.org/antihistamine-increase-risk-dementia/)

    Here, some anticholinergic drugs are listed:

    From the paper cited in the medscape articke:
    The authors of this study say:

Share This Page